Portfolio company
Brinter
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops 3D-bioprinted regenerative medical implants for healthcare providers to treat patients requiring breast reconstruction and orthopedic repairs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Klona Biotech
The company develops 3D-bioprinted structural human tissue implants, such as ligaments and tendons, for healthcare providers and patients requiring reconstructive surgery.
Bioaesthetics
This company develops biologically derived collagen grafts to regenerate nipples and areolas for patients undergoing breast reconstruction surgery after mastectomies.
CERHUM
This company manufactures 3D-printed bioceramic bone grafts and patient-specific implants for surgeons performing maxillofacial, dental, and orthopaedic reconstructions.
BioSapien
This company develops 3D-printed biodegradable mesh for localized and sustained delivery of chemotherapy drugs to cancer patients.
Cellbricks
Cellbricks develops 3D-bioprinted human tissue implants and vascularised therapeutics for patients with complex wounds, soft tissue defects and organ damage.
Dimension Bio
This company develops 3D-printed regenerative implants and tissue-like therapies to restore organ and tissue function for patients with disease, trauma, or ageing.
PRINTYMED
This company produces biomimetic spider silk materials for medical researchers, healthcare providers, and cosmetic manufacturers to enable regenerative treatments and sustainable product formulations.
Cellink
This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.
